First-in-Human Study of the CD123 NK Cell Engager SAR443579 in Relapsed or Refractory Acute Myeloid Leukemia, B-Cell Acute Lymphoblastic Leukemia or High Risk-Myelodysplasia: Updated Safety, Efficacy, Pharmacokinetics and PharmacodynamicsAshish Bajel, Anthony S. Stein, Nicolas Boissel et al.|Blood|2023Cited by 24
P494: A FIRST-IN-HUMAN STUDY OF CD123 NK CELL ENGAGER SAR443579 IN RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA, B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA OR HIGH RISK-MYELODYSPLASIAAnthony S. Stein, Ashish Bajel, Mojca Jongen‐Lavrencic et al.|HemaSphere|2023Cited by 2
Advanced laser-driven betatron X-ray generationM. Fuchs, B. A. Shadwick, Junzhi Wang et al.|Unknown|2023Cited by 0